NL7303331A - - Google Patents

Info

Publication number
NL7303331A
NL7303331A NL7303331A NL7303331A NL7303331A NL 7303331 A NL7303331 A NL 7303331A NL 7303331 A NL7303331 A NL 7303331A NL 7303331 A NL7303331 A NL 7303331A NL 7303331 A NL7303331 A NL 7303331A
Authority
NL
Netherlands
Application number
NL7303331A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7303331A publication Critical patent/NL7303331A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL7303331A 1972-03-13 1973-03-09 NL7303331A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23434772A 1972-03-13 1972-03-13
US00329001A US3856807A (en) 1972-03-13 1973-02-02 L-({60 s,5s)-{60 -amino-3-chloro-2-isoxazoline-5-acetic acid

Publications (1)

Publication Number Publication Date
NL7303331A true NL7303331A (xx) 1973-09-17

Family

ID=26927835

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7303331A NL7303331A (xx) 1972-03-13 1973-03-09

Country Status (13)

Country Link
US (1) US3856807A (xx)
JP (1) JPS5629997B2 (xx)
AR (1) AR198077A1 (xx)
AU (1) AU467524B2 (xx)
CA (1) CA984321A (xx)
CH (1) CH581698A5 (xx)
DK (1) DK132095C (xx)
FR (1) FR2183680B1 (xx)
GB (1) GB1382772A (xx)
IL (1) IL41598A (xx)
NL (1) NL7303331A (xx)
PH (1) PH9723A (xx)
SE (1) SE388434B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944562A (en) * 1974-04-17 1976-03-16 The Upjohn Company αS, 4S, 5R α-Amino-3-chloro-4-hydroxy-2-isoxazoline-5-acetic acid
US4298744A (en) * 1978-05-15 1981-11-03 The Upjohn Company Method for preparing (αS,5S)-α-amino-3-chloro-2-isoxazoline-5-acetic acid (AT-125) and analogs thereof
US4256898A (en) * 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
AU526380B2 (en) * 1978-05-15 1983-01-06 Upjohn Company, The 2-isoxazoline-5-acetic acid derivatives
US4275214A (en) * 1978-05-15 1981-06-23 The Upjohn Company Substituted alkoxy carbonyl-3-oxo-α-phthalimido-5-isoxozolidineacetic acids
USRE31578E (en) * 1978-05-15 1984-05-01 The Upjohn Company α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4225720A (en) * 1978-05-15 1980-09-30 The Upjohn Company Purification of AT-125
US4232164A (en) * 1978-05-15 1980-11-04 The Upjohn Company Purification of AT-125
US4692538A (en) * 1982-04-14 1987-09-08 Bristol-Myers Company Trichloroethanimidic acid esters
WO2014186435A2 (en) 2013-05-14 2014-11-20 University Of Georgia Research Foundation, Inc. Compositions and methods for reducing neointima formation
CA3163889A1 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Triantennary n-acetylgalactosamine modified hydroxyl polyamidoamine dendrimers and methods of use thereof
US20210170040A1 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery

Also Published As

Publication number Publication date
PH9723A (en) 1976-02-27
AU467524B2 (en) 1975-12-04
SE388434B (sv) 1976-10-04
FR2183680A1 (xx) 1973-12-21
GB1382772A (en) 1975-02-05
JPS5629997B2 (xx) 1981-07-11
DK132095C (da) 1976-03-15
CH581698A5 (xx) 1976-11-15
AU5247773A (en) 1974-08-22
CA984321A (en) 1976-02-24
JPS4899391A (xx) 1973-12-15
FR2183680B1 (xx) 1976-10-22
IL41598A (en) 1975-11-25
AR198077A1 (es) 1974-05-31
US3856807A (en) 1974-12-24
DK132095B (da) 1975-10-20
IL41598A0 (en) 1973-04-30

Similar Documents

Publication Publication Date Title
DK136239C (xx)
FR2183680B1 (xx)
JPS4945308A (xx)
CS155900B1 (xx)
JPS4945915A (xx)
JPS4934005U (xx)
JPS5728268B2 (xx)
CS155435B1 (xx)
CS153953B1 (xx)
CS156048B1 (xx)
CH583514A5 (xx)
CH577687A5 (xx)
CH590061A5 (xx)
CH589719A5 (xx)
CH589689A5 (xx)
CH589317B5 (xx)
CH589147A5 (xx)
CH589146A5 (xx)
CH587340A5 (xx)
CH574103A5 (xx)
CH583293A5 (xx)
CH582632A5 (xx)
CH581957A5 (xx)
CH580116A5 (xx)
CH580107A5 (xx)